# An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or Dialysis

> **NCT01309295** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 250 (actual)

## Conditions studied

- Anemia, Kidney Disease, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01309295
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01309295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01309295, "An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or Dialysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01309295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*